Kwality Pharmaceuticals Limited (KPL.BO)
INR 868.0
(0.32%)
INR 868.0
(0.32%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.07 Billion | 2.51 Billion | 4.56 Billion | 2.62 Billion | 1.39 Billion | 1.66 Billion |
| Cost of Revenue | 1.63 Billion | 1.19 Billion | 2.1 Billion | 1.71 Billion | 904.34 Million | 1.21 Billion |
| Gross Profit | 1.43 Billion | 1.31 Billion | 2.45 Billion | 906.8 Million | 488.63 Million | 443.93 Million |
| Operating Expenses | 248.93 Million | 857.21 Million | 850.19 Million | 680.24 Million | 370.9 Million | 317.97 Million |
| Selling, General and Administrative Expenses | 125.7 Million | 190.84 Million | 311.96 Million | 281.04 Million | 125.93 Million | 114.25 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.31 Billion | 14.98 Million | 17.26 Million | 10.42 Million | 12.2 Million | 4.09 Million |
| Cost and Expenses | 2.57 Billion | 2.05 Billion | 2.95 Billion | 2.39 Billion | 1.27 Billion | 1.53 Billion |
| Operating Income | 500.7 Million | 480.79 Million | 1.62 Billion | 239.6 Million | 129.76 Million | 127.05 Million |
| Interest Expense | 103.86 Million | 60.2 Million | 29.17 Million | 26.75 Million | 25.02 Million | 22.83 Million |
| Income Tax Expense | 74.83 Million | 62.92 Million | 416.28 Million | 63.84 Million | 27.1 Million | 33.53 Million |
| Earnings before Tax | 310.98 Million | 255.72 Million | 1.61 Billion | 212.71 Million | 109.17 Million | 109.1 Million |
| Net Income | 237.96 Million | 193.72 Million | 1.19 Billion | 151.45 Million | 83.17 Million | 75.52 Million |
| Earnings Per Share Basic | 22.93 | 18.67 | 115.64 | 14.60 | 8.02 | 7.28 |
| Earnings Per Share Diluted | 22.93 | 18.67 | 115.64 | 14.60 | 8.02 | 7.28 |
| Weighted Average Shares Outstanding | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million |
| Gross Margin | 0.47 | 0.52 | 0.54 | 0.35 | 0.35 | 0.27 |
| EBIT Margin | 0.20 | 0.25 | 0.38 | 0.12 | 0.13 | 0.10 |
| Profit Margin | 0.08 | 0.08 | 0.26 | 0.06 | 0.06 | 0.05 |
| EBITDA | 610.44 Million | 471.38 Million | 1.75 Billion | 304.44 Million | 178.49 Million | 163.12 Million |
| Earnings Before Tax Margin | 0.16 | 0.19 | 0.36 | 0.09 | 0.09 | 0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 900.34 Million | 800.78 Million | 919.77 Million | 3.07 Billion | 780.95 Million | 696.49 Million |
| Cost of Revenue | 588.79 Million | 527.67 Million | 600.96 Million | 2.05 Billion | 399.49 Million | 341.49 Million |
| Gross Profit | 311.55 Million | 273.11 Million | 318.81 Million | 1.01 Billion | 381.45 Million | 355 Million |
| Operating Expenses | 322.34 Million | 139.93 Million | 163.23 Million | 551.12 Million | 262.8 Million | 251.54 Million |
| Selling, General and Administrative Expenses | 161.17 Million | 139.93 Million | 163.23 Million | - | 134.51 Million | 123.44 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 161.17 Million | 2.77 Million | 5.82 Million | 18.3 Million | 6.17 Million | 2.33 Million |
| Cost and Expenses | 749.96 Million | 667.6 Million | 764.19 Million | 2.6 Billion | 662.29 Million | 593.03 Million |
| Operating Income | 150.38 Million | 133.18 Million | 155.57 Million | 467.54 Million | 118.65 Million | 103.46 Million |
| Interest Expense | - | 24.77 Million | 30.56 Million | 103.86 Million | 27.33 Million | 24.11 Million |
| Income Tax Expense | 40.98 Million | 27.71 Million | 17.46 Million | 74.83 Million | 20.72 Million | 19.53 Million |
| Earnings before Tax | 125.53 Million | 111.18 Million | 59.84 Million | 310.98 Million | 97.5 Million | 81.68 Million |
| Net Income | 84.7 Million | 83.56 Million | 44.47 Million | 237.96 Million | 76.9 Million | 62.35 Million |
| Earnings Per Share Basic | 8.16 | 8.05 | 4.08 | - | 7.41 | 6.01 |
| Earnings Per Share Diluted | 8.16 | 8.05 | 4.08 | - | 7.41 | 6.01 |
| Weighted Average Shares Outstanding | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million | 10.37 Million |
| Gross Margin | 0.35 | 0.34 | 0.35 | 0.33 | 0.49 | 0.51 |
| EBIT Margin | 0.17 | 0.22 | 0.22 | - | 0.22 | 0.22 |
| Profit Margin | 0.09 | 0.10 | 0.05 | 0.08 | 0.10 | 0.09 |
| EBITDA | 150.38 Million | 173.43 Million | 206.24 Million | - | 173.02 Million | 154.64 Million |
| Earnings Before Tax Margin | 0.17 | 0.17 | 0.17 | 0.15 | 0.15 | 0.15 |
VISI
HGH
EXLA
GHI
SOC
ALPM